The AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial: to believe or not to believe?

J Am Coll Cardiol. 2012 Jun 5;59(23):2065-7. doi: 10.1016/j.jacc.2012.02.021. Epub 2012 Apr 18.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cardiovascular Diseases / prevention & control*
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hypercholesterolemia / drug therapy*
  • Lipoproteins, HDL / blood*
  • Male
  • Niacin / therapeutic use*
  • Triglycerides / blood*

Substances

  • HDL-triglyceride
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipoproteins, HDL
  • Triglycerides
  • Niacin